(Q43221429)

16 November 2017

Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses (English)

1 reference

16 November 2017

Berk L

1

1 reference

16 November 2017

Schalm SW

series ordinal

2

1 reference

16 November 2017

Heijtink RA

series ordinal

3

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 October 1991

1 reference

16 November 2017

1 reference

16 November 2017

32

1 reference

16 November 2017

10

1 reference

16 November 2017

1198-1200

1 reference

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

16 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379385

Classification and treatment of chronic active liver disease

25 May 2018

1 reference

12 December 2020

Controlled trial of prednisone and azathioprine in active chronic hepatitis

1 reference

12 December 2020

Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome

1 reference

12 December 2020

Current concepts. Primary sclerosing cholangitis

1 reference

12 December 2020

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.32.10.1198

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

1955176

1 reference